Nutrien (NTR) Q4 2025 earnings summary

Executive summary

• Achieved adjusted EBITDA of $6.05 billion in 2025, up 13% year-over-year, with net earnings of $2.30 billion, record fertilizer sales volumes, and strong execution of strategic and cost reduction plans.

• Retail adjusted EBITDA increased to $1.74 billion, driven by cost reductions, margin improvement, and proprietary product growth, especially in Brazil.

• Executed portfolio simplification, including divestitures generating $900 million in proceeds, and increased cash returns to shareholders by 30%.

• Strengthened balance sheet by reducing short-term debt by over $600 million and repurchasing 2% of shares outstanding in 2025.

• Achieved 49% potash mine automation, enhancing productivity and safety.

Financial highlights

• Adjusted EBITDA reached $6.05 billion in 2025, a 13% increase from the prior year, with net earnings of $2.30 billion and sales of $26.89 billion.

• Retail adjusted EBITDA rose to $1.74 billion, surpassing cost savings targets.

• Potash adjusted EBITDA was $2.25 billion, Nitrogen $2.15 billion, and Phosphate $382 million.

• Free cash flow structurally increased, supporting debt reduction and higher shareholder returns.

• Diluted net earnings per share for 2025 were $4.66, up 243% from 2024.

Outlook and guidance

• 2026 guidance: Retail adjusted EBITDA of $1.75–$1.95 billion, Potash sales volumes of 14.1–14.8 million tonnes, Nitrogen 9.2–9.7 million tonnes, and Phosphate 2.4–2.6 million tonnes.

• Capital expenditures for 2026 guided at $2.0–$2.1 billion, with $400 million for growth investments.

• Nitrogen margin profile expected to improve due to operational enhancements and shutdowns at Trinidad and New Madrid.

• Ongoing strategic review of phosphate and Brazilian retail businesses, with decisions expected in 2026.

• Market outlook anticipates strong potash fundamentals, improved nitrogen margins, and higher Retail earnings.